• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管化在腰椎管狭窄症患者黄韧带机械性能变化和肥厚发展中的作用。

The role of vascularization on changes in ligamentum flavum mechanical properties and development of hypertrophy in patients with lumbar spinal stenosis.

机构信息

Department of Orthopedics and Traumatology, Third Medical Faculty of Charles University and University Hospital Kralovske Vinohrady, Srobarova 50, Praha 10, 100 34 Prague, Czech Republic.

Division of Biomechanics, Faculty of Mechanical Engineering, Czech Technical University in Prague, Czech Republic.

出版信息

Spine J. 2020 Jul;20(7):1125-1133. doi: 10.1016/j.spinee.2020.03.002. Epub 2020 Mar 13.

DOI:10.1016/j.spinee.2020.03.002
PMID:32179155
Abstract

BACKGROUND CONTEXT

Ligamentum flavum (LF) induced lumbar spinal stenosis (LSS) is conditioned not only by its "gathering" but especially by hypertrophy. Previous studies have examined the pathophysiology and biochemical changes that cause the hypertrophy. Some studies have described a link between chronic LF inflammation and neovascularization but others have reported highly hypovascular LF tissue in LSS patients. Currently, there is no practical application for our knowledge of the pathophysiology of the LF hypertrophy. Considerations for future treatment include influencing this hypertrophy at the level of tissue mediators, which may slow the development of LSS. To our knowledge, there is no study of micromechanical properties of native LF to date.

PURPOSE

(1) To clarify the changes in vascularization, chondroid metaplasia, and the presence of inflammatory cell infiltration in LF associated with LSS. (2) To quantify changes in the micromechanical properties associated with LF degenerative processes.

STUDY DESIGN/SETTING: Vascular density analysis of degenerated and healthy human LF combined with measurement of micromechanical properties.

METHODS

The study involved 35 patients who underwent surgery between November 1, 2015 and October 1, 2016. The LSS group consisted of 20 patients and the control group consisted of 15 patients. LF samples were obtained during the operation and were used for histopathological and nanoindentation examinations. Sample vascularization was examined as microvascular density (L), which was morphometrically evaluated using semiautomatic detection in conjunction with NIS-Elements AR image analysis software. Samples were also histologically examined for the presence of chondroid metaplasia and inflammation. Mechanical properties of native LF samples were analyzed using the Hysitron TI 950 TriboIndenter nanomechanical testing system.

RESULTS

Vascular density was significantly lower in the LSS group. However, after excluding the effect of age, the difference was not significant. There was high association between L and age. With each increasing year of age, L decreased by 11.5 mm. Vascular density decreased up to the age of 50. Over the age of 50, changes were no longer significant and L appeared to stabilize. No correlation was observed between L and the presence of inflammation or metaplasia; however, LSS patients had a significantly increased incidence of chondroid metaplasia and inflammatory signs. The mechanical properties of control group samples showed significantly higher stiffness than those samples obtained from the LSS group.

CONCLUSION

This study showed that L changes were not dependent on LSS but were age-dependent. Vascular density was found to decrease up to the age of 50. A significantly higher incidence of chondroid metaplasia and inflammation was observed in LSS patients. The mechanical property values measured by nanoindentation showed high microstructural heterogeneity of the tested ligaments. Our results showed that healthy ligaments were significantly stiffer than LSS ligaments.

CLINICAL SIGNIFICANCE

Prevention of the loss of LF vascularization during aging may influence stiffness of LF which in turn may slow down the LF degenerative processes and delay onset of LSS.

摘要

背景语境

黄韧带(LF)引起的腰椎管狭窄症(LSS)不仅与其“聚集”有关,还与其肥大有关。以前的研究已经研究了导致肥大的病理生理学和生化变化。一些研究描述了慢性 LF 炎症与新生血管形成之间的联系,但其他研究报告了 LSS 患者 LF 组织的高度低血管化。目前,我们对 LF 肥大的病理生理学的了解还没有实际应用。未来治疗的考虑因素包括在组织介质水平上影响这种肥大,这可能会减缓 LSS 的发展。据我们所知,迄今为止,还没有关于天然 LF 微机械性能的研究。

目的

(1)阐明与 LSS 相关的 LF 中血管生成、软骨样化生和炎症细胞浸润的变化。(2)量化与 LF 退行性过程相关的微机械性能的变化。

研究设计/设置:退变和健康人 LF 的血管密度分析结合微机械性能的测量。

方法

该研究涉及 2015 年 11 月 1 日至 2016 年 10 月 1 日期间接受手术的 35 名患者。LSS 组包括 20 名患者,对照组包括 15 名患者。在手术过程中获得 LF 样本,并用于组织病理学和纳米压痕检查。通过微脉管密度(L)检查样本的血管化情况,通过半自动检测与 NIS-Elements AR 图像分析软件相结合进行形态计量评估。还对软骨样化生和炎症的存在进行了组织学检查。使用 Hysitron TI 950 TriboIndenter 纳米力学测试系统分析天然 LF 样本的机械性能。

结果

LSS 组的血管密度明显较低。然而,在排除年龄影响后,差异并不显著。L 与年龄高度相关。每年增加一岁,L 减少 11.5 毫米。血管密度在 50 岁之前下降。50 岁以上,变化不再显著,L 似乎趋于稳定。L 与炎症或化生的存在之间没有观察到相关性;然而,LSS 患者的软骨样化生和炎症迹象明显增加。对照组样本的力学性能显示出明显高于 LSS 组样本的刚度。

结论

本研究表明,L 的变化不是依赖于 LSS,而是依赖于年龄。发现血管密度在 50 岁之前下降。LSS 患者的软骨样化生和炎症发生率明显更高。通过纳米压痕测量的力学性能值显示出所测试韧带的微观结构高度异质性。我们的结果表明,健康韧带明显比 LSS 韧带更硬。

临床意义

防止 LF 血管老化过程中的丢失可能会影响 LF 的刚度,从而减缓 LF 的退行性过程并延迟 LSS 的发生。

相似文献

1
The role of vascularization on changes in ligamentum flavum mechanical properties and development of hypertrophy in patients with lumbar spinal stenosis.血管化在腰椎管狭窄症患者黄韧带机械性能变化和肥厚发展中的作用。
Spine J. 2020 Jul;20(7):1125-1133. doi: 10.1016/j.spinee.2020.03.002. Epub 2020 Mar 13.
2
Expression and function of FGF9 in the hypertrophied ligamentum flavum of lumbar spinal stenosis patients.FGF9 在腰椎椎管狭窄症患者黄韧带肥厚中的表达及功能。
Spine J. 2021 Jun;21(6):1010-1020. doi: 10.1016/j.spinee.2021.02.004. Epub 2021 Feb 10.
3
Increased advanced glycation end products in hypertrophied ligamentum flavum of diabetes mellitus patients.糖尿病患者肥厚黄韧带中晚期糖基化终产物的增加。
Spine J. 2019 Oct;19(10):1739-1745. doi: 10.1016/j.spinee.2019.06.001. Epub 2019 Jun 10.
4
Increased pain and sensory hyperinnervation of the ligamentum flavum in patients with lumbar spinal stenosis.腰椎管狭窄症患者黄韧带疼痛和感觉神经支配增加。
J Orthop Res. 2019 Mar;37(3):737-743. doi: 10.1002/jor.24251. Epub 2019 Feb 28.
5
The correlation between imaging expression of P16 and S100 in hypertrophic ligamentum flavum.黄韧带肥厚中 P16 和 S100 影像学表达的相关性。
BMC Musculoskelet Disord. 2020 Jun 8;21(1):359. doi: 10.1186/s12891-020-03395-y.
6
Myofibroblasts are increased in the dorsal layer of the hypertrophic ligamentum flavum in lumbar spinal canal stenosis.在腰椎管狭窄症中,肥厚的黄韧带背侧层中肌成纤维细胞增多。
Spine J. 2022 Apr;22(4):697-704. doi: 10.1016/j.spinee.2021.11.003. Epub 2021 Nov 11.
7
GSK-3β and β-Catenin Signaling Pathway is Involved in Myofibroblast Transition of Ligamentum Flavum in Lumbar Spinal Stenosis Patients.GSK-3β 和β-连环蛋白信号通路参与腰椎管狭窄症患者黄韧带成肌纤维细胞的转化。
Spine (Phila Pa 1976). 2023 Oct 15;48(20):1472-1479. doi: 10.1097/BRS.0000000000004770. Epub 2023 Jul 6.
8
Distribution of mechanical properties of native human ligamentum flavum depending on histopathological changes.根据组织病理学变化分布的天然人黄韧带的机械性能。
Biomed Phys Eng Express. 2024 Sep 20;10(6). doi: 10.1088/2057-1976/ad78e2.
9
Factors associated with the thickness of the ligamentum flavum: is ligamentum flavum thickening due to hypertrophy or buckling?与黄韧带厚度相关的因素:黄韧带增厚是由于肥大还是折叠?
Spine (Phila Pa 1976). 2011 Jul 15;36(16):E1093-7. doi: 10.1097/BRS.0b013e318203e2b5.
10
Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor, and matrix metalloproteinases 1, 3, and 9 in hypertrophied ligamentum flavum.缺氧诱导因子-1α、血管内皮生长因子以及基质金属蛋白酶1、3和9在肥厚黄韧带中的表达
J Spinal Disord Tech. 2013 Oct;26(7):400-6. doi: 10.1097/BSD.0b013e3182495b88.

引用本文的文献

1
Single-cell multi-omics analysis identifies SPP1 macrophages as key drivers of ferroptosis-mediated fibrosis in ligamentum flavum hypertrophy.单细胞多组学分析确定SPP1巨噬细胞是黄韧带肥厚中 ferroptosis 介导的纤维化的关键驱动因素。
Biomark Res. 2025 Feb 25;13(1):33. doi: 10.1186/s40364-025-00746-6.
2
Variations in ECM Topography, Fiber Alignment, Mechanical Stiffness, and Cellular Composition Between Ventral and Dorsal Ligamentum Flavum Layers: Insights Into Hypertrophy Pathogenesis.腹侧和背侧黄韧带层之间细胞外基质拓扑结构、纤维排列、机械刚度和细胞组成的差异:对肥厚发病机制的见解。
JOR Spine. 2025 Jan 30;8(1):e70033. doi: 10.1002/jsp2.70033. eCollection 2025 Mar.
3
Decorin: a potential therapeutic candidate for ligamentum flavum hypertrophy by antagonizing TGF-β1.
核心蛋白聚糖:通过拮抗 TGF-β1 抑制黄韧带肥厚的潜在治疗靶点
Exp Mol Med. 2023 Jul;55(7):1413-1423. doi: 10.1038/s12276-023-01023-y. Epub 2023 Jul 3.
4
Administration of N-Acetylcysteine to Regress the Fibrogenic and Proinflammatory Effects of Oxidative Stress in Hypertrophic Ligamentum Flavum Cells.给予 N-乙酰半胱氨酸以逆转肥厚性黄韧带细胞氧化应激的纤维生成和促炎作用。
Oxid Med Cell Longev. 2022 Oct 26;2022:1380353. doi: 10.1155/2022/1380353. eCollection 2022.
5
Relationship between Severity of Lumbar Spinal Stenosis and Ligamentum Flavum Hypertrophy and Serum Inflammatory Factors.腰椎管狭窄症严重程度与黄韧带肥厚及血清炎症因子的关系。
Comput Math Methods Med. 2022 Oct 12;2022:8799240. doi: 10.1155/2022/8799240. eCollection 2022.
6
Clusterin negatively modulates mechanical stress-mediated ligamentum flavum hypertrophy through TGF-β1 signaling.簇集蛋白通过 TGF-β1 信号负调控机械应力介导的黄韧带肥厚。
Exp Mol Med. 2022 Sep;54(9):1549-1562. doi: 10.1038/s12276-022-00849-2. Epub 2022 Sep 21.
7
Spinal Biomechanical Modelling in the Process of Lumbar Intervertebral Disc Herniation in Middle-Aged and Elderly.中老年腰椎间盘突出症的脊柱生物力学模型。
J Healthc Eng. 2021 Oct 29;2021:2869488. doi: 10.1155/2021/2869488. eCollection 2021.
8
Dysregulation of MicroRNAs in Hypertrophy and Ossification of Ligamentum Flavum: New Advances, Challenges, and Potential Directions.黄韧带肥厚与骨化中微小RNA的失调:新进展、挑战及潜在方向
Front Genet. 2021 Apr 12;12:641575. doi: 10.3389/fgene.2021.641575. eCollection 2021.